Continuous Cardiac Telemetry Fused with High-Margin Unit Economics.
BeatioPulse unlocks the $45.8B ambulatory cardiology and wellness market by replacing lagging mail-in monitors with a high-margin single-use intelligent patch delivering real-time skin-to-cloud telemetry in under 800ms.
What is the BeatioPulse Investment Thesis?
The BeatioPulse™ investment thesis is built on disrupting the $45.8B ambulatory telemetry market with an ultra-low single-use cleanroom manufacturing cost structure (< $20 target COGS). By combining on-skin INT8 edge ML with sub-800ms cloud synchronization, it unlocks $154/month Medicare RPM reimbursement, generating $119 net practice profit per patient and 85%+ SaaS software margins.
Unit Economics & Dual-Revenue Model
Hardware gross margins combined with recurring high-margin cloud SaaS subscriptions.
| Economic Metric | BeatioPulse Model | Traditional Mail-In Holter (Zio) | Standard Hospital Telemetry |
|---|---|---|---|
| Hardware Cost per Episode | < $20 Target COGS (Single-use patch) | $85–$120 (Multi-part plastic pod + mail logistics) | $1,500+ (Tethered capital console) |
| Clinic Margin per Patient | $119.00 net / patient / month | Zero direct practice margin (Outsourced service) | High overhead / nurse labor intensive |
| Recurring SaaS Revenue | $15.00 / patient / month cloud OS fee | Included in diagnostic fee | Hospital IT license contracts |
| Software Gross Margin | 85%+ Cloud Margin | 40–55% Blended service margin | Varies by hospital network |
5-Stage Project Execution Roadmap
Clear capital deployment path from cleanroom tooling to nationwide commercialization.
Architecture & PCBA
COMPLETE4-layer rigid-flex PCBA fabricated. Nordic nRF5340 dual-core architecture validated with Bourns 2,000V defibrillation clamp protection.
Edge AI Quantization
COMPLETEINT8 neural network model benchmarked on 100,000+ MIT-BIH beats. QRS detection sensitivity achieved 99.8% with sub-12ms inference latency.
Cleanroom Tooling
IN PROGRESSLiquid silicone rubber (LSR) injection tooling, 1,200 mAh thin primary cell packaging, and pneumatic bed-of-nails ATE test fixtures.
150-Pt IRB Trial
Q1 2027Multi-center equivalence clinical study across 3 university cardiology centers establishing non-inferiority against 12-lead Holters.
FDA 510(k) Clearance
Q3 2027Substantial equivalence clearance under 21 CFR 870.2800. Commercial rollout targeting top 250 US cardiology practices.
Frequently Asked Diligence Questions
What is the current investment stage of BeatioPulse?
BeatioPulse is currently in its active Seed R&D financing phase, raising capital to complete cleanroom contract manufacturing tooling, execute the 150-patient multi-center IRB equivalence trial, and secure global patent protection.
What are the unit economics and gross margins of the BeatioPulse patch?
The single-use patch targets a cleanroom manufacturing COGS under $20 at volume scale. Wholesale pricing to cardiology practices is $35.00 (yielding strong hardware gross margins), supplemented by a recurring $15.00/month/patient cloud telemetry software license (85%+ SaaS gross margin).
What is the market size for continuous cardiac telemetry and RPM?
The total addressable market (TAM) spans $45.8 billion across global ambulatory cardiac monitoring and preventative longevity health, driven by CMS Medicare reimbursement codes paying $154.00/month per patient.
Participate in the BeatioPulse Seed Round
Contact our founding executive team to receive the comprehensive 45-page investor deck, financial pro-forma, and patent strategy documentation.